Interleukin-1 Receptor Antagonist: A Promising Cytokine against Human Squamous Cell Carcinomas

0
126
Scientists review the antitumor potential of interleukin-1 (IL-1) receptor antagonist as an IL-1-targeted inhibitor, in the context of human squamous cell carcinomas.
[Heliyon]
Full Article